The Cancer Drugs Fund (CDF) has today completed a further review of the effectiveness of treatments it funds to ensure it delivers the best outcomes for patients. The fund will no longer pay for 16 medicines used to treat a variety of cancers, including breast prostate and pancreatic cancer.
An update on the list can be found here
BBC Health News also recently reported the changes, read the news item here
The decision summaries can be found on NHS England website
